Announcement The alliances have evolved and faced the challenges together to build a healthy tomorrow. The latest partnership has been introduced in the vast healthcare market. The PolyActiva, a clinical-level biopharmaceutical company standing in a well-defined position with the novel drug deliver...
Announcement The Kardigan, the leading heart health company advancing cardiovascular (CV) drug development, has acquired Prolaio, a clinical-fuelled company modernising care and research with real-world patient insights and data. Additionally, Prolaio’s FDA-approved patient monitoring softwa...
Announcement SimplyTest® has signed a partnership agreement with Evexia Diagnostics, a leading provider of diagnostic laboratory services for unified and functional medicine. With this partnership deal, the two SimplyTests’ focused examinations, 4-point cortisol and SimplyTest PERIO, are...
Announcement The United Parcel Service (UPS), a leading logistics, supply chain and shipping management company, a known American multinational operating across 200 countries and territories, has acquired Andlauer Healthcare Group Inc. (AHG), a popular North American supply chain management compan...
Announcement IntoCell Inc., a leading biotechnology company establishing linker technologies and next-generation payload for antibody-drug conjugates (ADCs) and Xcellon Biologics, a known US contract development and manufacturing organisation (CDMO), an excellence holder in critical biologics and ...
Announcement PharmaDrug Inc., a leading speciality pharmaceutical company targeting the development, commercialisation and research of natural medicines, have entered a conclusive securities exchange agreement with Canurta Limited Partnership and its limited partners, said to be a parent entity of...
Announcement Savara Inc., a US-based clinical-level biopharmaceutical company focusing on rare respiratory diseases, has signed a $75 million royalty funding agreement with RTW Investments, LP, managing the funding process, which is entitled to FDA clearance of MOLBREEZI. The royalty financing wil...
Image Credit: Genprex Announcement Genprex, Inc., a leading clinical-level gene therapy company aiming to develop and advance life-changing therapies for diabetes and cancer patients, has signed a definitive agreement for the sale and purchase of 377.780 shares of common stock at a buyout ...
Image Credit: Faeth Therapeutics Announcement Faeth Therapeutics, a leading clinical-level biotechnology company focusing on the advancement of specific therapies focusing on tumour metabolism, has declared one more advancement of its popular PIKTOR regimen in endometrial cancer. Additionally, t...
Image Credit: www.bms.com Announcement The Evotec SE, honouring its smart neuroscience collaboration, has announced that the company has received the milestone (profit) payment worth US$25M from Bristol Myers Squibb on its scientific progress gained within this partnership. The payment wil...
